ReportWire

Tag: ob-gyn

  • Early prenatal care, considered best for moms and babies, is on the decline in the US, data shows

    [ad_1]

    Early prenatal care improves the chances of having a healthy pregnancy and baby. But a new federal report shows it’s been on the decline.The share of U.S. births to women who began prenatal care in the first trimester dropped from 78.3% in 2021 to 75.5% in 2024, according to data released by the Centers for Disease Control and Prevention on Thursday.Meanwhile, starting care later in pregnancy or getting no care at all has been on the rise. Prenatal care beginning in the second trimester rose from 15.4% to 17.3%, and starting care in the third trimester or getting no care went from 6.3% to 7.3%.“We know that early engagement in prenatal care is linked to better overall health outcomes,” said Dr. Clayton Alfonso, an OB-GYN at Duke University in North Carolina. When patients delay medical care during pregnancy, “we’ve missed that window to optimize both fetal and maternal care.”While the trend identified in the report held for nearly all racial and ethnic groups, the decrease in early prenatal care was higher for moms in minority groups. For example, first-trimester care dropped from 69.7% in 2021 to 65.1% in 2024 for Black mothers. Getting late or no prenatal care raises the risk of maternal mortality, which is much higher among Black mothers.Michelle Osterman, lead author of the report, said the overall findings represent a shift. Between 2016 and 2021, the timing of when U.S. women started prenatal care had been improving.The earlier prenatal visits begin, doctors said, the earlier problems can be caught. Visits give doctors a chance to share health guidance, and can include blood pressure checks, screenings, blood tests, physical exams and ultrasound scans.The report doesn’t provide reasons why prenatal care is starting later. But the proliferation of maternity care deserts across the nation is a growing concern, said Dr. Grace Ferguson, an OB-GYN in Pittsburgh.Many hospitals have shut down labor and delivery units “and the prenatal care providers that work at those hospitals also have probably moved,” said Ferguson, who was not involved with the report.A 2024 March of Dimes report found that more than 35% of U.S. counties are maternity care deserts, meaning there’s no birthing facility or obstetric provider. Women living in these areas receive less prenatal care, the report showed.Ferguson, who provides abortions as part of her OB-GYN care, said post-Roe v. Wade abortion restrictions may play a part because some obstetricians are choosing not to practice in states with more restrictive laws.Alfonso, who was not involved in the CDC report, said he also suspects that access issues for patients are pushing prenatal care later, particularly in rural areas. Patients may have to travel farther to get to appointments and may struggle to find a practice that accepts their insurance, particularly if they have Medicaid.Doctors fear that things could get worse.“If this trend continues,” Alfonso said, “I worry about kind of what that would mean for morbidity and mortality for our moms.”

    Early prenatal care improves the chances of having a healthy pregnancy and baby. But a new federal report shows it’s been on the decline.

    The share of U.S. births to women who began prenatal care in the first trimester dropped from 78.3% in 2021 to 75.5% in 2024, according to data released by the Centers for Disease Control and Prevention on Thursday.

    Meanwhile, starting care later in pregnancy or getting no care at all has been on the rise. Prenatal care beginning in the second trimester rose from 15.4% to 17.3%, and starting care in the third trimester or getting no care went from 6.3% to 7.3%.

    “We know that early engagement in prenatal care is linked to better overall health outcomes,” said Dr. Clayton Alfonso, an OB-GYN at Duke University in North Carolina. When patients delay medical care during pregnancy, “we’ve missed that window to optimize both fetal and maternal care.”

    While the trend identified in the report held for nearly all racial and ethnic groups, the decrease in early prenatal care was higher for moms in minority groups. For example, first-trimester care dropped from 69.7% in 2021 to 65.1% in 2024 for Black mothers. Getting late or no prenatal care raises the risk of maternal mortality, which is much higher among Black mothers.

    Michelle Osterman, lead author of the report, said the overall findings represent a shift. Between 2016 and 2021, the timing of when U.S. women started prenatal care had been improving.

    The earlier prenatal visits begin, doctors said, the earlier problems can be caught. Visits give doctors a chance to share health guidance, and can include blood pressure checks, screenings, blood tests, physical exams and ultrasound scans.

    The report doesn’t provide reasons why prenatal care is starting later. But the proliferation of maternity care deserts across the nation is a growing concern, said Dr. Grace Ferguson, an OB-GYN in Pittsburgh.

    Many hospitals have shut down labor and delivery units “and the prenatal care providers that work at those hospitals also have probably moved,” said Ferguson, who was not involved with the report.

    A 2024 March of Dimes report found that more than 35% of U.S. counties are maternity care deserts, meaning there’s no birthing facility or obstetric provider. Women living in these areas receive less prenatal care, the report showed.

    Ferguson, who provides abortions as part of her OB-GYN care, said post-Roe v. Wade abortion restrictions may play a part because some obstetricians are choosing not to practice in states with more restrictive laws.

    Alfonso, who was not involved in the CDC report, said he also suspects that access issues for patients are pushing prenatal care later, particularly in rural areas. Patients may have to travel farther to get to appointments and may struggle to find a practice that accepts their insurance, particularly if they have Medicaid.

    Doctors fear that things could get worse.

    “If this trend continues,” Alfonso said, “I worry about kind of what that would mean for morbidity and mortality for our moms.”

    [ad_2]

    Source link

  • Virginia lawmakers send reproductive rights amendment toward November vote – WTOP News

    [ad_1]

    Unlike two other civil rights-related constitutional amendments that passed with bipartisan support over the past year, Virginia’s reproductive rights measure has faced intense debate at every stage, with every Republican in the legislature opposing it. 

    This article was reprinted with permission from Virginia Mercury

    A proposal allowing mid-decade redistricting of Virginia’s congressional maps that cleared the legislature last week may dominate debate heading into a spring special referendum, but a constitutional amendment on reproductive rights is poised to ignite similar fervor as the November election approaches.

    Unlike two other civil rights-related constitutional amendments that passed with bipartisan support over the past year, Virginia’s reproductive rights measure has faced intense debate at every stage, with every Republican in the legislature opposing it.

    In defending her amendment for the final time, Sen. Jennifer Boysko, D-Fairfax, emphasized that advancing the proposal would ultimately leave the decision to voters across the state.

    Ranging from fertility treatments to contraception access to the ability to obtain an abortion, “this amendment protects families’ entire scope of reproductive needs,” she said.

    Boysko and several other Democratic lawmakers have described how women in states with abortion bans have died amid pregnancy complications. Those states have also seen an exodus of OB-GYN physicians amid uncertainty of treating patients who need abortions or miscarriage management.

    Boysko grew tearful as she recounted stories and advocacy shared by constituents and people around the state.

    Relatedly, Sen. Emily Jordan, R-Isle of Wight, struck a somber tone as she noted that “this is a difficult topic for a lot of people.”

    On the opposite side of the chamber’s aisle — and in opposition to the amendment — Jordan unsuccessfully attempted to modify the proposal to explicitly spell out care for babies when born.

    A sticking point for some Republicans has been concern that the amendment could be interpreted to allow abortion up to the “moment of birth,”  though infanticide remains illegal under both state code and federal law.

    Sen. Tara Durant, R-Stafford, also attempted for the second legislative session in a row, to reiterate existing parental consent laws. Democrats and legal experts said it is unnecessary. Under Virginia law, minors are required to have parental or guardian consent for an abortion unless they petition a judge for authorization.

    On Thursday, Senate Majority Leader Scott Surovell, D-Fairfax, accused Republicans of employing delay tactics by pressing for their amendments to the amendment.

    “It is a delay tactic,” Sen. Mark Obenshain, R-Rockbridge, said on Friday, as he urged lawmakers to re-draft the amendment. Doing so, however, would restart the two-year process.

    A sense of urgency

    While not entirely a partisan issue at the national level, the issue has increasingly fallen along party lines in states. That dynamic, Virginia Wesleyan University professor Leslie Caughell said, helps explain why Democrats are moving quickly while they hold legislative majorities.

    Though placing language in the Constitution is difficult, it is also harder to undo. With every other Southern state imposing deep restrictions or near-total bans, bolstering Virginia’s protections has become a priority for Democrats. Providers and abortion funds in Virginia have also seen a surge in out-of-state patients seeking care.

    “I think everything that happened in North Carolina made activists on this really uncomfortable,” Caughell said.

    In 2023, a member of the neighboring state’s legislature switched from Democrat to Republican, giving the GOP a veto-proof majority and paving the way for enactment of North Carolina’s current 12-week abortion limit.

    In Virginia, Republicans have also put forward a range of abortion restrictions, from near-total bans to a 15-week cap that lacked exceptions for fetal anomalies — which are often not detected until around or after 15 weeks.

    On other reproductive health issues, a right-to-contraception bill has twice been vetoed by former Gov. Glenn Youngkin — a point Boysko reiterated as the amendment advanced last week.

    ‘Yes’ and “No’ campaigns on the horizon

    Reproductive rights groups in Virginia, along with physicians and volunteers, have coordinated as part the national Reproductive Freedom for All effort. Last year, a $5 million investment supported targeted initiatives ranging from canvassing to digital advertising in states such as Virginia, where Abigail Spanberger was elected governor.

    Spanberger campaigned in part on supporting the amendment, though governors do not formally factor into its success or failure.

    “I look forward to spending ample time in advance of the 2026 elections campaigning to make sure that people understand the importance of this constitutional amendment,” she told The Mercury last summer.

    On the other side, SBA Pro-Life America supported Virginia-based anti-abortion groups last year through door-knocking efforts in key House of Delegates districts that were up for election.

    Democrats ultimately grew their majority by flipping additional seats.

    The abortion-opposing group “doesn’t have anything to share on the Virginia front at this time,” Communications Director Kelsey Pritchard said in an email, but the organization is monitoring Virginia among other states as it prepares to engage voters.

    Virginians for Reproductive Freedom — which includes organizations like Repro Rising and Planned Parenthood Advocates of Virginia — will likely ramp up public engagement events and advertising as the November elections approach.

    Caughell said she is watching closely to see how Virginia’s constitutional amendment campaigns intersect with this year’s congressional midterm elections.

    The measures — which include redistricting, reproductive rights, same-sex marriage rights and voting rights — arrive at a moment when Democrats may have an advantage, she noted.

    Midterm elections are often a referendum on the party that controls the White House, Caughell said.

    With Republican President Donald Trump in the White House, GOP majorities in Congress, and federal funding fallouts affecting states, the amendments championed by Democrats could also help drive down-ballot votes.

    She also noted that abortion, as a distinct health care need, has become a more salient argument in recent years, alongside economic considerations and support for personal choice.

    “We’ve expanded the parameters of our understanding of who this issue directly affects,” Caughell said.

    Speaking with reporters outside the Senate chamber Friday, Sen. Mamie Locke, D-Hampton, emphasized that the work is not finished.

    “It’s our responsibility to go out there and tell the voters this is what this means and help everybody understand what they’re voting for,” she said.

    [ad_2]

    LaDawn Black

    Source link

  • NYU Langone opens new care center in Commack | Long Island Business News

    [ad_1]

    NYU Langone opened an 18,000-square-foot, two-floor center at 167 Veterans Memorial Highway.

    NYU Langone Ambulatory Care Commack offers family medicine, cardiology, orthopedics, plastic surgery, obstetrics and gynecology, colorectal surgery, urology, dermatology and endocrinology services. It includes nearly 30 exam rooms and a procedure room, as well as on-site stress echocardiogram testing and X-ray capabilities.

    “Rapidly expanding our presence on , particularly in Suffolk County, brings greater access to NYU Langone’s top-quality care closer to where our patients live and work,” Andrew Rubin, senior vice president for clinical affairs and ambulatory care at NYU Langone, said in a news release about the Commack center.

    “Our latest in Commack enables patients to see multiple doctors in a single visit, with each provider connected seamlessly by our electronic record,” Rubin said.

    The Commack site marks the sixth NYU Langone practice to open in Suffolk County this year.

    “The new site in Commack reflects our continued commitment to thoughtful design and its important connection to health, wellness, and comfort,” Vicki Match Suna, executive vice president and vice dean for real estate development and facilities at NYU Langone, said in the news release.

    “Our design approach here, and at all of our locations, is founded on a consistent vision—one that prioritizes sustainability, functionality, and aesthetics to best support our patients, staff, and the broader community,” Suna said.


    [ad_2]

    Adina Genn

    Source link

  • Women’s Health IT and Software Innovations Undergo Rapid Expansion: Black Book Research Releases Comprehensive 2025 Industry Report

    [ad_1]

    Black Book Research today unveiled its most expansive study to date on the women’s health information technology (IT) landscape, delivering a data-rich, 94-page report that captures the surging momentum of digital innovation across fertility, menopause, maternal health equity, virtual OB-GYN ecosystems, and predictive analytics.

    Based on responses from 455 provider organizations, 91 payer executives, and 72 employer stakeholders, the report evaluates more than 300 vendors across 40 specialized categories using 18 qualitative key performance indicators (KPIs) tailored to women’s health. These performance metrics include clinical specificity, interoperability, policy alignment, whole-person care, and health equity responsiveness.

    “This year’s findings mark a seismic shift in how women’s health IT is funded, built, and adopted,” said Doug Brown, Founder of Black Book Research. “The days of retrofitting generic tools into women’s health specialties are over-buyers now expect targeted, inclusive, and outcome-driven platforms that address clinical complexity and care equity across the entire lifecycle.”

    Stakeholders, investors and industry media can access the report with no cost at https://blackbookmarketresearch.com/2025-black-book-of-womens-health-information-technology-and-software-innovations

    Unprecedented Growth in Market Value and Innovation

    The global women’s health IT market is expected to surpass $14.8 billion by year-end 2025, with projections exceeding $22 billion by 2028. The U.S. market alone now accounts for $7.6 billion of that total, driven by payer adoption, employer benefits expansion, and the rise of AI-powered clinical platforms.

    Notable subsegment market sizes in 2025 include:

    Virtual OB-GYN & Reproductive Health: $3.3B globally ($1.8B U.S.)

    Fertility Tech & IVF Platforms: $2.2B globally ($1.1B U.S.)

    Menopause Tech: $1.4B globally ($720M U.S.)

    Maternal Health Equity Tools: $1.6B globally ($800M U.S.)

    Investment, M&A, and Startup Demand Surge

    Between 2022 and 2025, over $5.6 billion in venture capital has flowed into women’s health IT startups, with breakout growth in menopause and Medicaid-aligned maternal health solutions. Startups such as Maven Clinic, Kindbody, and Carrot Fertility are now viewed as IPO-watch candidates, while mid-stage firms in digital therapeutics, reproductive diagnostics, and SDoH analytics are attracting strategic acquirers and PE recapitalization.

    The report identifies over 100 early- and mid-stage startups to watch and profiles 30 top-performing electronic health record (EHR) platforms most aligned with OB-GYN, fertility, breast health, menopause, and women’s behavioral health practices. ModMed, NextGen Healthcare, Netsmart, athenahealth, and DrChrono led in client satisfaction among women’s health-focused clinicians.

    Regulatory and Policy Pressures Drive Adoption

    Women’s health IT buyers now face a complex web of mandates and incentives. CMS’s “Birthing-Friendly” designation, post-Dobbs reproductive data privacy constraints, and TEFCA-aligned interoperability requirements are accelerating both product innovation and procurement timelines.

    The Black Book report includes dedicated chapters on:

    Maternal Health Equity & SDoH Analytics

    Menopause Tech & Midlife Health

    Virtual OB-GYN Ecosystems

    FemTech Integration into Clinical Settings

    Personalized & Predictive Women’s Health Platforms

    Buyer Sentiment: From Fragmentation to Platform Consolidation

    Surveyed providers and payers overwhelmingly signaled a desire to consolidate fragmented tools into longitudinal platforms that span hormonal health, pregnancy, postpartum, and menopause care. Gaps remain in EHR menopause modules, perinatal behavioral health integration, and culturally competent design.

    Procurement is now increasingly led by cross-functional teams, including medical directors, benefits managers, equity officers, and patients themselves. Vendor responsiveness, implementation support, and health equity alignment were repeatedly cited as deciding factors in 2025 purchasing.

    Top-Ranked EHR Vendors for Women’s Health Specialties (Q1 2025)

    ModMed – OB-GYN, fertility, and urogynecology workflow leadership

    NextGen Healthcare – Integrated chronic and reproductive care tracking

    Netsmart Technologies – Maternal and behavioral health coordination

    athenahealth – Telehealth-enabled OB episode management

    DrChrono – Mobile-first EHR for individualized women’s care

    Additional recognition was given to 25 more vendors across OB-GYN, oncology, menopause, and behavioral health niches.

    About Black Book Research

    Black Book™ independently surveys healthcare professionals and consumers to identify high-performing IT vendors and services. With over 3 million global survey respondents and no vendor sponsorships, Black Book provides trusted, unbiased rankings and market insights across more than 200 healthcare sectors. Black Book Market Research proudly delivers independent, data-driven insights to the healthcare industry-grounded in verified client experience, globally recognized research standards, and a steadfast commitment to vendor neutrality. We maintain our integrity by not offering consulting services, performance improvement programs, or acting as intermediaries between IT buyers and vendors, ensuring that our rankings, reports, and recognition are never influenced by payments or promotional partnerships. To support the healthcare community year-round, we provide complimentary resources and data updates, while sustaining our research operations through customized data services for technology buyers and competitive intelligence scorecards for vendors seeking clarity, benchmarking, and market insight. Our mission is built on trust, transparency, and the belief that healthcare decisions deserve to be guided by real experiences-not commercial bias.

    Source: Black Book Research

    [ad_2]

    Source link

  • Getting an IUD can hurt. New guidelines say doctors should help patients manage the pain

    Getting an IUD can hurt. New guidelines say doctors should help patients manage the pain

    [ad_1]

    Gynecology nurse practitioner Stephanie Edwards-Latchu has performed over 450 intrauterine device insertions. Some women will barely notice when the device is placed, she said, but others report the worst pain they will ever feel.The devices, which are placed within the uterus to prevent pregnancy, are the third most common form of birth control in the U.S. Still, some patients have come to her after being dismissed by other providers — told to “calm down” or that their pain is “not that bad” or even “you’re being dramatic.”In new contraceptive guidance published this week, the U.S. Centers for Disease Control and Prevention gave updated recommendations for clinicians on how to help manage the pain some people may have when the devices, known as IUDs, are inserted. Lidocaine “might be useful for reducing patient pain” when injected as a local anesthetic or applied topically as a numbing gel, cream or spray, the CDC said in the update, the first since 2016.The CDC also recommends doctors inform all patients about potential pain and personalize IUD placement and pain management plans for each individual.The individualized and patient-centered language is a large shift from the 2016 guidelines, which were less specific and less detailed, according to Dr. Tessa Madden, professor of obstetrics, gynecology and reproductive sciences at the Yale School of Medicine.Madden’s research on the use of lidocaine was referenced in the updated guidelines. However, she noted, her research is nearly 12 years old — highlighting the longstanding challenge in improving pain management during the procedure.In a 2019 survey of about 1,000 family planning providers, less than 5% reported using a lidocaine injection during IUD insertion. Instead, they more frequently suggested ibuprofen, which research has shown does not reduce insertion pain.”Saying to take ibuprofen is the bare minimum, and it’s not enough,” said Edwards-Latchu, whose campus health clinic at University of North Carolina Chapel Hill offers lidocaine gel and injections, heating pads, Valium and the option to bring a supporting person. The clinic is also experimenting with umbilical vibration devices that might reduce discomfort during the procedure.The procedure to insert an IUD takes about 15 minutes or less. A health care provider performs a pelvic exam and then uses a speculum to widen the vagina, through which they place the device within the uterus.”Any one of those steps can be uncomfortable for people—from the pelvic examination to the IUD insertion—although it’s typically the insertion that’s the most uncomfortable, when they experience the highest level of pain,” said Dr. Beverly Gray, an associate professor of obstetrics and gynecology at Duke University and an obstetrician and gynecologist at Duke Health.Cramping and other uncomfortable or painful sensations can occur during and after insertion, as the procedure involves using pointed forceps called a tenaculum to stabilize the cervix and passing the intrauterine device through the narrow cervical canal.”Patients have clearly spoken out about their traumatic or painful experiences,” Gray added. “These guidelines highlight the importance of discussing pain management and being frank about the spectrum of experiences that people might have.”‘My pain is not being taken seriously’Female pain has long been underrecognized and undertreated.”Women have been saying for decades, ‘my pain is not being taken seriously,” Edwards-Latchu said. “It feels like screaming into the void.”A 2021 study found that pain in female patients is consistently underestimated due to gender stereotypes, and women are judged to benefit less from pain medicine than men, despite equal likelihood of seeking care.”In medicine, we historically have not done a very good job of taking women’s pain, in particular, seriously,” added Madden.Edwards-Latchu described a female patient whose appendix ruptured after her abdominal pain was dismissed as menstrual cramps, pointing to a broader issue of women’s pain being mismanaged. Research echoes this, showing women in emergency rooms with similar abdominal pain scores to men waited longer and were less likely to receive pain relief.This issue also extends to IUD insertion, where studies have shown patients report significantly higher pain levels than providers perceive.There is no guaranteed way to predict an individual’s response to an IUD insertion, according to Madden, who said that some of her patients have high levels of pain while others experience “very little.”However, increased pain during the procedure is more likely if the patient hasn’t had a vaginal birth, has a history of painful periods or has experienced trauma.Some research also suggests that anxiety is associated with worse pain across various medical procedures.”There is a variety of experiences that people have. It’s sometimes hard to predict who will have an easy experience with insertion and who will have a more challenging experience,” Gray added. “Understanding that is important.”A 2014 study of 109 IUD recipients found that 78% reported pain ranging from moderate to severe upon insertion. That range is clear on TikTok, where numerous women have shared live videos from the exam table as their IUDs were inserted.”IUD insertion is the worst pain imaginable,” wrote one user who showed herself writhing in pain.”This was the most excruciating pain I’ve ever experienced,” another shared.In both videos, the health-care providers inserting the IUDs could be heard telling their patients to expect pressure or a “pinch.”Social media shows part of the picture”It’s heartbreaking,” Edwards-Latchu said of the videos on her social media feed. “The first thing that I think is, ‘I doubt they were given anything for their pain,’ and to me, that is upsetting.”The videos bring awareness to the potential pain, she said, adding that it’s important “to know about the negative experiences so that something changes.”However, according to Madden, the videos can also dissuade viewers from considering a contraceptive option that could be a viable option for them.”Patients come into the office talking about videos that they’ve seen on TikTok or Instagram, which is where a lot of times patients are getting their information from,” she said. “Seeing a video like that could be a significant deterrent.”Intrauterine devices have had a tumultuous history. Notably, the Dalkon Shield in the 1970s caused cases of severe infection and other complications, casting a long shadow over the safety of IUDs. However, modern IUDs have been proven to be safe and effective, and are used by over 10% of women aged 15 to 49, according to CDC data from 2017-2019. They can last for up to 10 years or more and are 20 times better at preventing unintended pregnancies than birth control pills and other short-term contraceptive methods, according to a 2012 study.” is a highly effective method that many patients are very satisfied with,” Madden added. “For some patients, the concern about pain with insertion is the reason that they’re not using .”If patients feel like we’re addressing their concerns about the pain, and taking the concerns seriously, then that might increase people’s willingness to use the method.”What to ask your doctorThe updated guidelines come as there’s a rise in demand for contraception after the reversal of Roe v. Wade in 2022.Edwards-Latchu explained that each year around graduation, her campus health clinic sees a surge of students seeking IUDs. Many of these students were preparing to move to areas with restrictive reproductive health laws and are unsure about future access to reproductive care.”They are looking at long-acting, reversible contraceptive methods like the IUD, and if they have one already, they want a newer one so they have longer protection,” she said. “It is something that you can hide and that somebody can’t take away from you, especially if you’re going to a state where contraception could be a target.”This context makes comprehensive and individualized conversations on insertion pain management more important than ever, she added.Gray, Madden and Edwards-Latchu say the increasing attention to insertion pain, long-term contraceptives and the new guidelines present an opportunity for providers to listen to their patients to create better personal experiences for them.Patients should actively ask questions during their consultation appointments to facilitate this, particularly about pain management options and anxiety support, they said.Edwards-Latchu suggests asking about lidocaine blocks, gels, sprays and other pain control methods as described in new CDC guidelines.”If a patient feels like the clinician is not taking their concern seriously or not willing to offer them some of these potential interventions.. then maybe that individual doesn’t want to get IUD with that clinician,” Madden added.”We need to be taking this pain seriously.”CNN’s Jacqueline Howard contributed to this report.

    Gynecology nurse practitioner Stephanie Edwards-Latchu has performed over 450 intrauterine device insertions. Some women will barely notice when the device is placed, she said, but others report the worst pain they will ever feel.

    The devices, which are placed within the uterus to prevent pregnancy, are the third most common form of birth control in the U.S. Still, some patients have come to her after being dismissed by other providers — told to “calm down” or that their pain is “not that bad” or even “you’re being dramatic.”

    In new contraceptive guidance published this week, the U.S. Centers for Disease Control and Prevention gave updated recommendations for clinicians on how to help manage the pain some people may have when the devices, known as IUDs, are inserted. Lidocaine “might be useful for reducing patient pain” when injected as a local anesthetic or applied topically as a numbing gel, cream or spray, the CDC said in the update, the first since 2016.

    The CDC also recommends doctors inform all patients about potential pain and personalize IUD placement and pain management plans for each individual.

    The individualized and patient-centered language is a large shift from the 2016 guidelines, which were less specific and less detailed, according to Dr. Tessa Madden, professor of obstetrics, gynecology and reproductive sciences at the Yale School of Medicine.

    Madden’s research on the use of lidocaine was referenced in the updated guidelines. However, she noted, her research is nearly 12 years old — highlighting the longstanding challenge in improving pain management during the procedure.

    In a 2019 survey of about 1,000 family planning providers, less than 5% reported using a lidocaine injection during IUD insertion. Instead, they more frequently suggested ibuprofen, which research has shown does not reduce insertion pain.

    “Saying to take ibuprofen is the bare minimum, and it’s not enough,” said Edwards-Latchu, whose campus health clinic at University of North Carolina Chapel Hill offers lidocaine gel and injections, heating pads, Valium and the option to bring a supporting person. The clinic is also experimenting with umbilical vibration devices that might reduce discomfort during the procedure.

    The procedure to insert an IUD takes about 15 minutes or less. A health care provider performs a pelvic exam and then uses a speculum to widen the vagina, through which they place the device within the uterus.

    “Any one of those steps can be uncomfortable for people—from the pelvic examination to the IUD insertion—although it’s typically the insertion that’s the most uncomfortable, when they experience the highest level of pain,” said Dr. Beverly Gray, an associate professor of obstetrics and gynecology at Duke University and an obstetrician and gynecologist at Duke Health.

    Cramping and other uncomfortable or painful sensations can occur during and after insertion, as the procedure involves using pointed forceps called a tenaculum to stabilize the cervix and passing the intrauterine device through the narrow cervical canal.

    “Patients have clearly spoken out about their traumatic or painful experiences,” Gray added. “These guidelines highlight the importance of discussing pain management and being frank about the spectrum of experiences that people might have.”

    ‘My pain is not being taken seriously’

    Female pain has long been underrecognized and undertreated.

    “Women have been saying for decades, ‘my pain is not being taken seriously,” Edwards-Latchu said. “It feels like screaming into the void.”

    A 2021 study found that pain in female patients is consistently underestimated due to gender stereotypes, and women are judged to benefit less from pain medicine than men, despite equal likelihood of seeking care.

    “In medicine, we historically have not done a very good job of taking women’s pain, in particular, seriously,” added Madden.

    Edwards-Latchu described a female patient whose appendix ruptured after her abdominal pain was dismissed as menstrual cramps, pointing to a broader issue of women’s pain being mismanaged. Research echoes this, showing women in emergency rooms with similar abdominal pain scores to men waited longer and were less likely to receive pain relief.

    This issue also extends to IUD insertion, where studies have shown patients report significantly higher pain levels than providers perceive.

    There is no guaranteed way to predict an individual’s response to an IUD insertion, according to Madden, who said that some of her patients have high levels of pain while others experience “very little.”

    However, increased pain during the procedure is more likely if the patient hasn’t had a vaginal birth, has a history of painful periods or has experienced trauma.

    Some research also suggests that anxiety is associated with worse pain across various medical procedures.

    “There is a variety of experiences that people have. It’s sometimes hard to predict who will have an easy experience with insertion and who will have a more challenging experience,” Gray added. “Understanding that is important.”

    A 2014 study of 109 IUD recipients found that 78% reported pain ranging from moderate to severe upon insertion. That range is clear on TikTok, where numerous women have shared live videos from the exam table as their IUDs were inserted.

    “IUD insertion is the worst pain imaginable,” wrote one user who showed herself writhing in pain.

    “This was the most excruciating pain I’ve ever experienced,” another shared.

    In both videos, the health-care providers inserting the IUDs could be heard telling their patients to expect pressure or a “pinch.”

    Social media shows part of the picture

    “It’s heartbreaking,” Edwards-Latchu said of the videos on her social media feed. “The first thing that I think is, ‘I doubt they were given anything for their pain,’ and to me, that is upsetting.”

    The videos bring awareness to the potential pain, she said, adding that it’s important “to know about the negative experiences so that something changes.”

    However, according to Madden, the videos can also dissuade viewers from considering a contraceptive option that could be a viable option for them.

    “Patients come into the office talking about videos that they’ve seen on TikTok or Instagram, which is where a lot of times patients are getting their information from,” she said. “Seeing a video like that could be a significant deterrent.”

    Intrauterine devices have had a tumultuous history. Notably, the Dalkon Shield in the 1970s caused cases of severe infection and other complications, casting a long shadow over the safety of IUDs. However, modern IUDs have been proven to be safe and effective, and are used by over 10% of women aged 15 to 49, according to CDC data from 2017-2019.

    They can last for up to 10 years or more and are 20 times better at preventing unintended pregnancies than birth control pills and other short-term contraceptive methods, according to a 2012 study.

    “[An IUD] is a highly effective method that many patients are very satisfied with,” Madden added. “For some patients, the concern about pain with insertion is the reason that they’re not using [it].

    “If patients feel like we’re addressing their concerns about the pain, and taking the concerns seriously, then that might increase people’s willingness to use the method.”

    What to ask your doctor

    The updated guidelines come as there’s a rise in demand for contraception after the reversal of Roe v. Wade in 2022.

    Edwards-Latchu explained that each year around graduation, her campus health clinic sees a surge of students seeking IUDs. Many of these students were preparing to move to areas with restrictive reproductive health laws and are unsure about future access to reproductive care.

    “They are looking at long-acting, reversible contraceptive methods like the IUD, and if they have one already, they want a newer one so they have longer protection,” she said. “It is something that you can hide and that somebody can’t take away from you, especially if you’re going to a state where contraception could be a target.”

    This context makes comprehensive and individualized conversations on insertion pain management more important than ever, she added.

    Gray, Madden and Edwards-Latchu say the increasing attention to insertion pain, long-term contraceptives and the new guidelines present an opportunity for providers to listen to their patients to create better personal experiences for them.

    Patients should actively ask questions during their consultation appointments to facilitate this, particularly about pain management options and anxiety support, they said.

    Edwards-Latchu suggests asking about lidocaine blocks, gels, sprays and other pain control methods as described in new CDC guidelines.

    “If a patient feels like the clinician is not taking their concern seriously or not willing to offer them some of these potential interventions.. then maybe that individual doesn’t want to get IUD with that clinician,” Madden added.

    “We need to be taking this pain seriously.”

    CNN’s Jacqueline Howard contributed to this report.

    [ad_2]

    Source link

  • One OB-GYN Wades Through The Muddled Waters Of Texas’s Abortion Ban

    One OB-GYN Wades Through The Muddled Waters Of Texas’s Abortion Ban

    [ad_1]

    Dr. Damla Karsan, a Houston-based obstetrics and gynecology specialist, says she experiences the everyday intimidation that comes as a result of Texas’s restrictive abortion ban when caring for patients whose health conditions are at risk due to complicated pregnancies.

    Karsan found herself and one of these patients, Kate Cox, at the center of the state’s reproductive health battleground last year when Cox sued Texas to get an abortion after learning her pregnancy was non-viable.

    Despite a lower court’s ruling that Karsan could perform the abortion, the Texas Supreme Court intervened, determining that Cox would not be able to receive one. Before the court’s decision, in a last-ditch effort to protect her health and future fertility, Cox’s legal team announced she was traveling out of state to obtain the procedure.

    Local reproductive rights advocates and healthcare officials alike continue to urge politicians and statewide medical organizations for clarity surrounding the so-called medical exemptions linked to Texas law that prohibits abortions unless the pregnant person’s life or a major bodily function is at risk.

    “Patients are getting sicker every day, every week that passes,” Karsan said. “So, we need to be able to respond in real time and do what the standard of care is. That’s all we are asking for. To provide the standard of care to our patients.”

    “We need to be able to respond in real time and do what the standard of care is. That’s all we are asking for. To provide the standard of care to our patients.”

    tweet this

    According to David Donatti, senior staff attorney at the American Civil Liberties Union of Texas, with the whittling down of the state bans, reproductive health-related litigation and advocacy is no longer focused on reinstating access to abortions. Instead, it concentrates on requesting clarification of laws and doctors’ ability to make medical decisions.

    This is occurring in Texas and across the nation, as the U.S. Supreme Court heard oral arguments this week in a case involving Idaho’s abortion ban that challenges whether a federal law that requires emergency stabilizing care, including abortions, overrides the state mandate that only permits these procedures if without them a person would die.

    The Emergency Medical Treatment and Labor Act, which is at the core of the lawsuit brought forth by the Biden Administration, requires all hospitals participating in Medicare to provide stabilizing care to patients having a medical emergency. If these facilities fail to comply, they risk losing the ability to participate in Medicare and state health programs and could have their provider agreements ended. 

    Joshua Turner, chief of constitutional litigation and policy for the Idaho Attorney General’s Office, argued that the state was within its jurisdiction to decide how to practice medicine. Justices Sonia Sotomayor and Elena Kagan pelted Turner with hypothetical cases of medical emergencies related to pregnancy, asking him what would happen in these situations.

    Turner said each would be evaluated on a case-by-case basis. There was no objective standard, only a subjective one based on whether the physician made a good-faith decision. Sotomayor pointed out that this response was the problem.

    U.S. Solicitor General Elizabeth Prelogar clarified to the conservative justices that the case was not about Idaho’s overall ban but about the state’s ability to criminalize essential care.

    Justices Clarence Thomas and Brett Kavanaugh appeared to favor Idaho like most of their other more conservative peers, despite Kavanaugh’s questioning of Turner.

    Justice Amy Coney Barrett, who is notably against abortion, occasionally veered to her left-leaning colleagues’ sides to question why the high-risk hypotheticals were not exempted under the state’s ban if they posed the possibility of death.

    “The case in front of the Supreme Court is very narrow,” Donatti said. “It is really about a circumstance where an individual needing an abortion presents themselves to an emergency room and whether a facility can turn them away or require them to go elsewhere.”

    “When we talk about this federal law, we’re talking about a small number of people,” he added. “But for those people, this is critically important. This is their livelihood, their ability to have families in the future.”

    For many pregnant people, hospitals serve as a place for primary and maternity care. This is often the case in states like Texas, where roughly 50 percent of the state’s 254 counties were considered maternal health deserts and did not have OB-GYNs or birthing facilities according to 2023 data.

    Donatti said what happens in the Idaho case could affect what occurs in a similar case in Texas that is currently pending in the courts. Unlike in Idaho, Texas Attorney General Ken Paxton initiated a lawsuit against the Biden Administration, arguing that the federal government could not require hospitals to offer emergency abortions.

    According to the Texas Medical Board, its guidance aligns the state’s ban with federal law. However, legal experts indicate that this may be unlikely given the lack of clarity about what kinds of cases fall under Texas’s exemption and which don’t.

    The board started initial evaluations and proposals of guidelines to define these exceptions, but those in the reproductive healthcare community argued further work was needed. The guidelines will either be modified or adopted in June.

    Donatti noted that one key aspect of both Texas and Idaho laws is that they’re very severe and limited, arguably more so than what the federal law requires. Texas’s legal challenge continues to play out in court.

    Most recently, the U.S. Fifth Circuit Court of Appeals sided with Texas. Donatti said if the ruling is challenged and the case makes it up to the country’s highest court, it would likely not be heard before October 2025. A decision on the Idaho case could come sometime this June.

    “The problem is if you have a vaguely defined medical exemption that divests doctors of their ability to do their job, and then you throw heavy criminal sanctions on top of it, what you do is you ultimately deprive patients of essential health care,” he said.

    “We have stacked the balance so that a physician gets this exception, but if they make the calculus wrong—and that decision will be made by individual prosecutors or by Paxton — then they lose your medical license, livelihood, profession, and entire liberty for up to 99 years,” he added.

    According to Karsan, having the ability, experience, and skills to know what needs to be done for her patients but having her hands tied legally is difficult.

    “Our training teaches us to mitigate risks. These are standards of care based on minimizing the risk to the patient and preserving their health and life,” Karsan said. “Not waiting until they’re on death’s door to intervene, and that’s really what the laws have done.”

    She said several of her colleagues are afraid to speak to their patients out of fear they’ll be called out for aiding and abetting an abortion due to the language of Senate Bill 8. This law, which passed in 2021, nicknamed the “Heartbeat Act,” allows anyone to bring a lawsuit against an individual they believe assists in the process of terminating a pregnancy.

    Karsan has practiced as an OB-GYN for nearly two decades. She said when she started her medical training, she didn’t anticipate that these legal obstacles would come later.

    However, when state lawmakers started chipping away at access to abortion by requiring ultrasounds before these operations or for patients receiving them to be in a surgical facility — she said she knew that overturning Roe v. Wade was next.

    It’s been almost two years since the Supreme Court struck down the constitutional right to an abortion, leaving the laws surrounding access to abortions to be determined state-by-state.

    Karsan said the number of applicants to Texas medical schools, especially OB-GYN residencies in Texas, is down, and the number of applicants for positions — even academic positions – has decreased, too.

    “Many of these individuals want to protect themselves, their families and their children from dealing with these issues,” Karsan noted. “So they choose to go to states with more access to care and quality reproductive choices.”

    “Our Legislature and our judiciary are trying to practice medicine without a license,” she added. 

    [ad_2]

    Faith Bugenhagen

    Source link

  • Pregnancy Can Change Your Shoe Size Forever

    Pregnancy Can Change Your Shoe Size Forever

    [ad_1]

    One night in July, a few weeks after my son was born, I lay awake, desperately scrolling through photos of injured feet. The mounting pain from an ingrown toenail in my right foot had become excruciating, and the internet promised to help. I could no longer deny the fact that the exorbitantly expensive Hoka sneakers I’d bought just months before—to prevent pregnancy-related foot pain—had become too small. To my horror, my feet had grown half a size. Permanently.

    Pregnancy books had informed me about the less rosy aspects of new motherhood, such as shedding hair (the baby’s and mine) and uncontrollable crying (the baby’s and mine). I was even prepared for my feet to temporarily swell through the trimesters. But no one told me they might stay that way. Unlike the rest of my body, my feet did not revert to their original size 9.5 after birth. Five months later, I am now the disgruntled guardian of a large infant—and even larger feet.

    Mom Feet is not a niche condition. Studies have found that anywhere from 44 to 61 percent of new moms experience lasting foot growth, and many seem to be surprised when it happens, just as I was. “Why does no one talk about the PERMANENT foot size changes after pregnancy?” one Reddit user lamented. My thoughts exactly.

    Temporary swelling in the feet (and hands) is a normal part of pregnancy, particularly in the third trimester. Extra fluid in the body tends to pool in “gravity-dependent areas,” causing ankles and toes to become noticeably puffy, Silvana Ribaudo, an ob-gyn at Columbia University Irving Medical Center, told me. This is not the same thing as Mom Feet, which I learned the hard way by wearing my Hokas long after they’d started to pinch.

    Foot swelling subsides after a person gives birth, but structural changes in the foot do not. Permanent foot growth, like most other disconcerting bodily changes that happen during pregnancy, can be attributed to hormones—in this case, one aptly named relaxin. It relaxes body tissue so that a growing baby can unfurl, then squiggle out. These changes are especially welcome in the pelvic region. In the feet, not so much.

    If a pre-pregnancy foot is like an ice-cream sandwich straight out of the freezer—sturdy, structured—one relaxed by relaxin is a sandwich left out in the sun. The hormone causes the ligaments and tendons in the foot and ankle to lose their rigidity and strength, so the foot tends to spread out, Alexandra Black, a podiatrist at Foot and Ankle Specialists of Central Ohio who co-authored a recent review of pregnancy-related foot changes, told me. Throwing pregnancy weight on them only compounds the problems. “It leads to more of a flatter foot, a wider foot, and a longer foot,” Black said. According to the few small studies on the topic, pregnant feet, on average, go up by roughly half a shoe size and lengthen by 0.4 inches. It is a small consolation that this effect is most pronounced during first pregnancies, meaning that feet won’t grow indefinitely along with one’s brood.

    It would have been nice to learn this before I bought my Hokas, of course. Had I known better, I probably wouldn’t have purchased so many Nike Air Maxes in recent years, or suggested to my husband that we buy matching white Jordans at an outlet mall during our honeymoon. Now those beloved shoes, along with the Hokas, have been banished to storage, while I’ve had to pay up for new winter boots, high heels, and sandals.

    Having to buy new shoes is expensive but admittedly kind of fun. Other consequences of Mom Feet are not. Footwear is annoying, because even a small shift in foot size can lead to shoes that don’t fit. And the collapse of the arch in your feet can be especially painful. Mine used to be graceful, like the arc of a leaping gazelle. Now the gazelle has face-planted. That’s because a tendon on the inside of the ankle, which normally acts like a bungee cable stabilizing the arch, goes slack during pregnancy. Lengthening and flattening this tendon can cause “a flat-foot deformity,” Black said, “and it’s kind of hard to reverse that.” Flat feet can cause the knee and tibia to over-rotate, throwing the bones and muscles involved in walking and standing into disarray—a “major contributor to pain” in pregnancy, one review noted. Conditions such as painful heels caused by plantar fasciitis, leg cramps, bunions, and nail issues are all linked to Mom Feet.

    Had I known about Mom Feet, I might have been better prepared for it. Some pregnant people and new moms find it helpful to use compression stockings to reduce swelling and get orthotics for extra arch support, Black said. Unfortunately, none of my doctors (who I should note were very good) warned me about it. Ditto for any pregnancy book I read, such as What to Expect When You’re Expecting, which said only that swelling of the feet was “normal” and “temporary.” I am far from the only person who has been caught off guard by newly big feet. Mystified mothers abound on pregnancy forums; colleagues told me they were “not warned” and “had no idea this was A Thing.”

    Perhaps the reason it is commonly overlooked is that, in the grand scheme of things that mothers-to-be have to deal with, such as gestational diabetes and life-threatening spikes in blood pressure, foot pain is relatively inconsequential. Because foot-size changes “are not concerning for the well-being of mom or baby,” they might not be deemed worthy of discussion, Leena Nathan, an ob-gyn at UCLA Health–Westlake Village, told me.

    But perhaps Mom Feet isn’t talked about because many things about it are still unknown. Not everyone experiences pain, and although permanent changes are well documented, feet might still possibly revert to their original size eventually. “It can take several years,” Ribaudo said, but “sometimes it never goes back.”According to Nathan, it isn’t well understood why some people experience changes in foot size and others don’t. Even the true prevalence of this condition isn’t known for certain, because the few studies that have examined it were small. One thing is clear, however: There is a dearth of research on foot changes during pregnancy, because pregnant women, in general, are understudied. People are “hesitant to do research on pregnant women, because it’s a sensitive population,” Black said.

    During my pregnancy, I was often shocked at how little was known about concerns both minor and monumental: whether eating pineapple would induce contractions, for example, or when the baby would actually be born. Walking, climbing stairs, and having sex are commonly recommended to help induce labor, but “it’s difficult to establish whether they actually worked—or whether labor, coincidentally, started on its own at the same time,” notes What to Expect When You’re Expecting. Pregnancy literature is rife with these sorts of equivocations. Many times over the trimesters, I wondered why so much of pregnancy still felt so medieval, full of guessing, folklore, and hearsay. It’s 2023: Why are new moms still surprised when their feet grow? To this, I have found few satisfactory answers. But at the very least, I have found an ingrown-toenail treatment that works.

    [ad_2]

    Yasmin Tayag

    Source link

  • Think Twice Before Testing Your Hormones at Home

    Think Twice Before Testing Your Hormones at Home

    [ad_1]

    Across the internet, a biological scapegoat has emerged for almost any mysterious medical symptom affecting women. Struggling with chronic fatigue, hair loss, brain fog, or dwindling sex drive? When no obvious explanation is at hand, an out-of-whack endocrine system must be to blame. Women have too much cortisol, vloggers and influencers say; or not enough thyroxine, or the wrong ratio of progesterone to estradiol. Social media is brimming with advice from self-proclaimed hormone “gurus” and health coaches; the tag #hormoneimbalance has racked up a staggering 950 million views on TikTok alone.

    Now dozens of start-ups promise to diagnose these imbalances from the comfort of your home. All it takes is the prick of a finger, a urine sample, or a vial of spit. You mail your sample out to a lab or run the test right in your kitchen, no co-pay or doctor visit required. A few days later, you receive a slick lab report and in some cases, a customized treatment plan to alleviate the depression, the insomnia, the feeling of just being off.

    Hormone imbalances can indeed contribute to an array of mental and physical symptoms, and hormone testing overseen by providers is a routine practice in medicine. Doing so remotely could theoretically improve women’s health and access to care. But despite their growing popularity and Amazon-like convenience, at-home hormone tests might cause more problems than they solve. Several women’s-health and hormone specialists told me that remote testing has long been useful for detecting pregnancy and tracking ovulation, but that few, if any, products now for sale have been consistently and rigorously proven to work for broader, newly advertised purposes. Testing kits are marketed as a way of helping women decipher puzzling symptoms or assess their fertility. But experts said that the technology—at least as it stands right now—is unreliable and could have the opposite effect, causing anxiety and confusion instead.

    Mindy Christianson, an ob-gyn and the medical director of the Johns Hopkins Fertility Center, told me that in the best-case scenario, an accurate home hormone test would lead its users to seek out necessary medical care for real medical problems. That’s what happened to Chrissy Rice, a 38-year-old in Georgia. From 2018 to 2022, Rice experienced a racing heart, panic attacks, skin rashes, fatigue, and stomach pain—but her blood work and cardiac tests kept coming back normal. Her doctor chalked her symptoms up to anxiety and prescribed an anxiolytic medication. Rice wasn’t satisfied, so she skipped the meds and ordered a $249 women’s-health-testing kit from a company called Everlywell. The kit, which uses saliva and finger-prick sampling, claims to check for abnormal hormone levels that may be keeping women from “feeling their best.” When Rice’s results lit up with four abnormal readings, she was “honestly relieved,” she told me: It gave her confidence that her symptoms hadn’t all been in her head. When she brought the results to another provider, he ordered more tests and eventually diagnosed her with an autoimmune condition called Hashimoto’s, for which she’s since been treated.

    Rice’s success story relied on a lot of things going right: The test correctly flagged that something about Rice’s body chemistry had gone awry. (In this case, #hormoneimbalance really did apply.) In response, Rice used her results to advocate for appropriate care from a trusted health provider. But not everyone is so lucky.

    Tests like the one Rice took rely on processes that have not yet been rigorously validated in clinical trials. Where traditional hormone testing involves in-person blood draws followed by a highly sensitive and specific process called liquid chromatography–tandem mass spectrometry, home tests typically use dried urine, dried blood, or saliva sampling and a variety of techniques for measuring what’s in those samples. Women have, of course, been peeing on pregnancy-testing sticks since the 1980s. But these tests work well because the target hormone is present at relatively high levels, and should be found only during pregnancy. By contrast, hormones such as estradiol, testosterone, and progesterone—which are commonly targeted by this new wave of start-ups’ tests—regularly circulate throughout the body during various stages of a woman’s life, and are far trickier to measure using the low-volume samples involved in dried urine, dried blood, and saliva tests.

    A handful of small studies from the past three decades (many of which are funded by direct-to-consumer testing companies or conducted by their employees) suggest that these methods may be accurate. Jennifer Conti, an ob-gyn physician and professor at the Stanford University School of Medicine who advises the home-hormone-testing start-up Modern Fertility, told me that the company’s internal data, especially a study published in the peer-reviewed journal Obstetrics & Gynecology in 2019, convinced her that its technology was useful for consumers who want to make more informed family-planning decisions. “But this idea that at-home testing is a godsend is not true,” Conti said. “It’s something that can be very helpful right now for a certain population of people to open the door and start a conversation.”

    Other experts still aren’t confident that the tests are worthwhile. I asked Andrea Dunaif, a professor and specialist in endocrinology and women’s health at Mount Sinai, and Hershel Raff, an endocrinology and molecular-medicine expert at the Medical College of Wisconsin, to review the 2019 study. According to the study’s authors, their findings suggest that Modern Fertility’s finger-stick testing methods can be used interchangeably with traditional blood draws to measure fertility-related hormones. But Dunaif and Raff pointed out a laundry list of methodological issues that they argue limit the power of the findings: The type of assay used isn’t accurate for determining testosterone or estradiol levels in women. Researchers didn’t use appropriate hormone-level ranges to test accuracy. Samples were analyzed within 48 hours—a timeline that doesn’t match up with real-world shipping. (Current leadership and members of Modern Fertility’s clinical-research team declined multiple requests for comment. But Erin Burke, a clinical researcher who co-authored the study and is no longer working for Modern Fertility, said she stands by the data. She told me that the team’s work shows that these testing methods are accurate and precise.)

    Although many experts see minimal data to support their use, at-home tests can still be sold on account of a regulatory loophole: The FDA does not typically review what it calls “low risk general wellness” products before they hit the market. Some endocrinologists advise looking for home hormone tests with a certification from the Clinical Laboratory Improvement Amendments program (which is legally required for every direct-to-consumer testing company) or the College of American Pathologists, both of which ensure that a company’s labs maintain certain quality standards and undergo regular inspections. But Dunaif told me the certifications don’t guarantee precise results. She would never recommend that consumers use a currently available product for testing women’s sex steroid hormones remotely, she said, arguing that people will waste money and likely get information that is either “falsely reassuring or falsely distressing.” (Dunaif recently consulted for Quest Diagnostics, a large clinical-lab chain that doesn’t offer home hormone tests.)

    Charlotte, a New Jersey woman in her mid-30s, experienced the muddle of uncertain results firsthand. (I’m identifying her by only her first name to protect her medical privacy.) In 2021, Charlotte ordered a hormone panel from Modern Fertility after she began experiencing irregular periods. Her results showed an abnormally high level of prolactin, a hormone involved in ovulation and lactation, which made her think she might be infertile. Charlotte spent days scouring the internet for information while she waited to discuss the results with her doctor. When she finally showed her ob-gyn the Modern Fertility report, the doctor was incredulous. She basically dismissed the at-home results out of hand, and instead put Charlotte on progesterone. A few months later, Charlotte got pregnant.

    Like Rice’s home test, Charlotte’s helped her start a conversation with a trusted health-care provider and develop a plan. But Charlotte told me that the process wasn’t worth the panic-filled waiting game and desperate Googling. She wishes she’d skipped the home test and consulted her doctor first.

    Even when home hormone tests are accurate, their results are not diagnostic on their own. Drawing a straight line from hormone levels to a diagnosis is impossible without a medical history or physical exam; a user can’t predict her chances of pregnancy, for example, solely based on measurements of her fertility-related hormones. Nor would low levels of, say, estradiol or progesterone be enough to indicate endometriosis. Most people’s symptoms aren’t tied directly to a hormone imbalance, says Stephanie Faubion, the director of the Mayo Clinic Center for Women’s Health and the medical director of the North American Menopause Society. The more than 50 chemical messengers that coordinate all kinds of processes, including metabolism, reproduction, and mood, are constantly fluctuating and difficult to measure with a quick-hit hormone test, Faubion told me; people’s symptoms may be attributable to multiple interrelated factors. “Just checking a hormone level and saying Here’s your problem doesn’t serve women well,” she said. “It’s oversimplifying an issue.”

    Some companies offer physician-reviewed reports, chat services, or phone calls with health providers to clarify any confusion. But Mary Jane Minkin, a gynecologist, menopause expert, and clinical professor at Yale School of Medicine, told me that those services might not be enough to curb misinterpretation, especially if test results aren’t reliable. Minkin worried that users may make drastic lifestyle changes or take off-the-shelf supplements. Christianson, of the Johns Hopkins Fertility Center, said that a growing number of her patients visit her clinic believing they are infertile or in premature menopause based on abnormal readings, when it’s not true. Others are rushing to freeze their eggs unnecessarily. And Faubion worries that providers, too, might use tests that aren’t evidence-based to make decisions about hormone therapy for patients. Some testing start-ups already offer personalized treatment plans and bioidentical hormone-replacement therapy via telehealth based on a user’s results.

    Other experts had the opposite concern: that women whose home-test results appear normal would miss out on crucial interventions. Christianson told me that she’s seen men skip out on necessary infertility evaluations based on at-home semen tests. Women could end up making similar mistakes. And Dunaif said that women experiencing chronically irregular periods might be falsely reassured by a home hormone test and delay needed treatment for endocrine disorders or polycystic ovarian syndrome (PCOS).

    At-home-hormone-testing companies aim to solve a pressing demand for clarity and control as women address their medical needs. If women have been tempted to blame their hormones for anything that’s wrong, that’s at least partly because they aren’t receiving sufficient guidance from doctors. For decades, female patients have been dismissed, misdiagnosed, and mistreated by their health providers more than male patients have. Far less clinical research has been conducted on women than men, which can make health care a guessing game. A diagnosis for a hormone disorder such as PCOS or endometriosis typically takes consultations with several doctors across two to 10 years. Plus, traditional hormone testing can be expensive, and specialists are difficult to find. Only 1,700 reproductive endocrinologists and 2,000 menopause specialists practice in the United States; fertility clinics are rare outside cities.

    In an ideal world, women wouldn’t feel the need to circumvent their doctors to test their hormones at home. But as it stands, many are desperate for answers, and direct-to-consumer testing companies are responding to their frustrations. Someday, the tests might help point users to the appropriate specialist, provide useful information for women in medical deserts, or enable people to better monitor chronic conditions for which the relevant hormones are simple to measure. But until they are rigorously evaluated, women are left with imperfect choices.

    [ad_2]

    Ali Pattillo

    Source link